ADIL: Adial Pharmaceuticals Inc. Earnings per share for the last twelve months

Official company branding of Adial Pharmaceuticals (ADIL)

Adial Pharmaceuticals is developing a comprehensive addiction treatment system by integrating the drug AD04 into psychiatric practice. The 12-month net income per share trend illustrates the business recovery process, where the -16.62 mark reflects the current state. The current budget relies exclusively on investor capital due to a lack of sales, while market positions are protected from direct dumping by patents.

ADIL (Adial) Net earnings per share (EPS TTM) history from 07/04/2022 to 10/29/2026

Metric breakdowns and analytics for Adial (ADIL)

- current quotes and average value forecast:
Price Chart Adial Pharmaceuticals, Inc.|ADIL - Fair Value Consensus
- market capitalization information:
Market Value Adial Pharmaceuticals, Inc.|ADIL - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Adial Pharmaceuticals|ADIL - Book Capitalization|Market Capitalization to Book Value Ratio adialpharma.com|ADIL - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Adial Pharmaceuticals|ADIL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Adial Pharmaceuticals|ADIL - Company Aggregate Debts|Debt to Book Capitalization Ratio Adial|ADIL - Company Long-Term Debt|Company Current Liabilities Adial Pharmaceuticals|Quick Liquidity adialpharma.com
- net income and valuation multiples indicators:
ADIL - Profit After Tax|Projected Future Earnings Adial Pharmaceuticals|ADIL - Company Value to Net Income|Forward P/E Multiple Adial Pharmaceuticals|ADIL - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adial Pharmaceuticals, Inc.|ADIL - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Adial Pharmaceuticals|ADIL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth adialpharma.com|ADIL - Earnings growth in current year|Earnings growth forecast for next year Adial Pharmaceuticals
- sales and revenue data:
ADIL - Company Sales|Projected Sales Volume Adial|ADIL - Price to Sales|Forward Price-to-Revenue Multiple Adial Pharmaceuticals Inc.
Analysis of all company metrics:ADIL - Adial Pharmaceuticals Inc.
Manufactured products of Adial Pharmaceuticals Inc.

Adial Pharmaceuticals' personalized approach to addiction therapy directly impacts the future monetization of genetic tests. This indicator reflects the portion of net income attributable to a single common share over a rolling year. The metric allows for an assessment of the actual efficiency of business scaling by excluding the influence of the total volume of issuance. For the investor, this serves as a tool for analyzing return on capital amid regulatory risks. The trend in the rolling net income per share visualizes the pace at which the company's fundamental successes are being capitalized.

Competitor analysis for Adial Pharmaceuticals

INDV - Earnings per share for the last twelve months|Earnings per share for the trailing year COLL (Collegium Pharma)|Cronos Corp (CRON) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Tweed|HITI (High Tide Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) auroramj.com|Net earnings per share (EPS TTM) ACHV|Net earnings per share (EPS TTM) Skye Bioscience (SKYE)|Net earnings per share (EPS TTM) ANEB (anebulo.com)|Earnings per share for the last four quarters INCR (Canndoc)|NTRB - Earnings per share for the last twelve months|NSRX - Net earnings per share (EPS TTM)|IGC: Net earnings per share (EPS TTM)|MIRA Pharma - Earnings per share for the trailing year|Net earnings per share for the last 12 months FLGC|Earnings per share for the last 12 months IMCC (imcannabis.com)|Net earnings per share for the last 12 months ARTL (Artelo Biosciences Inc.)|ENSC - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) TTNP (Titan Pharmaceuticals)|GNLN: Earnings per share for the last 12 months|INM - Earnings per share for the last twelve months|AKAN - Net earnings per share (EPS TTM)|ENVB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bright Green Corp. (BGXX)|Earnings per share for the last twelve months hempaccoinc.com